TRAF6 and cancer: The present study therefore raises the possibility that a drug inhibiting the TRAF6 E3 ligase activity may also unleash the power of cytotoxic T cells to destroy cancer cells, without developing the serious adverse effects seen in TRAF6 KO mice.